Pharyngolaryngeal ulcers associated with the improper use of alendronate

Auris Nasus Larynx. 2017 Dec;44(6):762-765. doi: 10.1016/j.anl.2016.11.002. Epub 2016 Dec 10.

Abstract

Bisphosphonates can cause mucosal irritation. Although esophageal ulceration is a well-recognized adverse effect of bisphosphonates, pharyngolaryngeal ulcers associated with the improper use of oral bisphosphonates have rarely been described. A previously healthy 78-year-old woman presented with refractory pharyngolaryngeal ulcers. Extensive evaluation, including biopsy, bacterial culture, and blood tests did not identify any findings that indicated a specific disease diagnosis. Antibiotics and oral prednisolone were ineffective. Ultimately, it was found that the patient regularly took a tablet of alendronate, a type of bisphosphonate, by dissolving it in the oral cavity. Within 2 weeks after withdrawal of the use of the medication, her symptoms were eliminated, and the lesions were completely healed. This case illustrates the importance of correct administration of bisphosphonates. Given the widespread use of bisphosphonates, physicians need to be aware that their improper use can cause pharyngolaryngeal ulcers.

Keywords: Adverse effect; Alendronate; Bisphosphonates; Improper use; Pharyngolaryngeal ulcer.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Alendronate / administration & dosage
  • Alendronate / adverse effects*
  • Bone Density Conservation Agents / administration & dosage
  • Bone Density Conservation Agents / adverse effects*
  • Female
  • Humans
  • Laryngeal Diseases / chemically induced*
  • Osteoporosis / drug therapy*
  • Pharyngeal Diseases / chemically induced*
  • Ulcer / chemically induced*

Substances

  • Bone Density Conservation Agents
  • Alendronate